Although tuberculosis can be cured by regular intake of antimicrobial drugs, it continues to be a serious world public health problem. The World Health Organization (WHO) estimates that 8 million cases of tuberculosis were reported in 2000, of which 1.87 million were fatal due to late diagnosis or noncompliance with treatment [1] .
In Brazil, it is estimated that nearly 50 million people have been infected by Koch's bacillus. According to Health Ministry data, approximately 90,000 new tuberculosis cases are reported annually, of which 10 to 30% are treated by secondary and tertiary Health Care Units and 6% are fatal [2, 3] . In the state of Goiás, 1,052 new tuberculosis cases were reported in 1998, with an incidence coefficient of 22.2/100,000 and lethality of 10%. Of that total, 35% were treated at the HDTAA in the city of Goiânia [3] .
TB/HIV co-infection is giving rise to fresh concerns regarding tuberculosis control due to the rising hospitalization rate and the need for new treatment strategies [4, 5] .
www.infecto.org.br/bjid.htm One of the main difficulties involved in meeting the goals of tuberculosis control programs (TCP) is poor compliance with antimicrobial treatment [6] [7] [8] . Nationwide in Brazil, the noncompliance rate varies between 12% and 16%, although noncompliance among TB patients in major cities (usually state capitals) varies between 27% and 34% [9] . Some international studies have also investigated factors associated with noncompliance with treatment [10] [11] [12] [13] [14] [15] . Most were carried out at primary or secondary health care units. However, few studies have evaluated patients who initiated tuberculosis treatment at a hospital, particularly in large urban centers [16] [17] [18] .
In a meta-analysis of noncompliance with medication, Haynes et al. [18] found that it is common. Although there have been numerous studies on the efficacy of treatment with new drugs, most of which are clinical trials financed by the pharmaceutical industry (stage I, II and III trials), stage IV clinical trials are rarely financed by governmental organizations. Usually, stage IV trials evaluate the effectiveness of new antimicrobial treatments in different populations, the causes of noncompliance, and the cost effectiveness of the different strategies [19] .
The objective of this study was to evaluate factors involved in noncompliance with tuberculosis treatment at HDTAA in the state of Goiás, a tertiary reference hospital for infectious and parasitic diseases -including AIDS and tuberculosis -in order to develop strategies for increasing the effectiveness of the treatment of this endemic disease.
Design
This study was carried out at the Anuar Auad Hospital for Tropical Diseases (HDTAA), a public hospital run by the State Health Department that is a regional reference for infectious and parasitic diseases. It has 126 beds and treats approximately 15,000 outpatients and 2,500 inpatients annually.
We analyzed a retrospective cohort study of all TB patients who initiated specific treatment at HDTAA between January and December 1998. Follow-up periods ranged between 6 and 24 months after the conclusion of treatment.
We identified patients by consulting records of notification forms. A standard form (annex 1) was used to collect data from each patient's medical records. Data was also recovered for the patients transferred to other health care units who were cured, noncompliant or who died, or whose treatment failed. The data was then analyzed and correlated with the final outcome of treatment. The final results were compared with data from the state TB control program.
The TB patients' diagnoses were obtained through bacilloscopy or microbacterial cultures, and some patients' attending physicians considered the probability of cure on the basis of clinical-epidemiological data and additional tests (PPD and chest X-ray). [3] The final outcomes of treatment included cure, noncompliance, death, transfer from health unit, change in diagnosis and treatment failure. Patients were treated provided by a team of professionals trained to treat TB patients (1 doctor/one nurse) or by professionals who carry out routine hospital procedures without prior specific training in TB treatment. Patients were chosen at random for treatment by of these groups of health care workers. Depending on the day they were hospitalized or scheduled an outpatient consultation, possible TB patients or those with firm diagnoses were treated by the health workers on duty at that time. No financial incentives were given to these patients for participation in the treatment program.
Admission to HDTAA was decided on the basis of the seriousness of their clinical condition, the presence of side effects and, in some cases, due to social problems.
Data for noncompliant patients were compared with those for cured patients. In these two groups of patients, factors potentially associated with noncompliance with TB treatment were compared, such as gender, skin color, marital status, origin (place of residence), employment status, alcohol use, HIV infection, comorbidities, prior TB treatment, need for hospitalization, clinical form of the disease (pulmonary, extrapulmonary or disseminated), bacilloscopy results, type of antimicrobial regimen used, adverse effects of TB medication and type of health care given by the two teams of health care workers (with and without specific tuberculosis training).
The study was approved by HDTAA's Research Ethics Board.
To analyze the variables studied, we used the chisquared test or Fisher's exact test., Statistically significance (alpha = 0.05) was determined through logistical regression in the multivariate analysis, and proximate values were included in the univariate analysis. Stata 5 statistical software was used.
Results
An evaluation of notification forms in medical records and the progress of patients registered with the State Tuberculosis Control Program enabled us to include in the final statistical analysis, 67 noncompliant patients and 186 patients considered cured, out of 341 patients who initiated TB treatment at HDTAA (Figure 1) . Tables 1 and 2 show the parameters for all 341 patients. They were predominantly male (67.4%), aged between 20 and 49 (68.9%), and resided in the city of Goiânia and neighboring municipalities (69.2%). TB/ AIDS co-infection was 10.1% and alcohol consumption, 25.2%. Among other associated comorbidities, tobacco smoking, diabetes and epilepsy were the most prevalent, respectively 15.2%, 4.7% and 4.7%. The percentage of patients undergoing retreatment was 20.8% and 42.2% of those whose condition developed into an actual disease state were admitted to the HDTAA. Pulmonary tuberculosis was present in 80.7% of all cases and 84.3% showed a positive bacilloscopy at the beginning of treatment. The TB control program team treated only 30.2% of all patients. Of a total of 301 patients, the cure rate found was 61.8%, noncompliance, 22.2%, death, 12% and treatment failure, 4%. The rest were transferred or had a change in diagnosis.
Univariate analysis showed no significant difference between noncompliant and cured patients with regard to gender, age, color, marital status, origin, employment status or HIV co-infection, however alcohol consumption was a predictive factor for noncompliance ( Table 3 ). The presence of adverse effects of treatment regiments also proved not to be significant.
Reported cases involving retreatment, the need for hospitalization or treatment by health care workers who were not trained to treat TB patients and the use of an antimicrobial regiment other than regimen I (Rifampin + Isoniazide + Pyrazinamide) were significantly associated with noncompliance (Table 4) .
After multivariate analysis, it was found that treatment by health care workers who are not trained to treat TB patients, the need for hospitalization and non-use of regimen I were significantly associated with the group of patients who were noncompliant with TB treatment (Table 5) .
Discussion
The benefits of curing a tuberculosis patient go beyond the individual, since it is a significant step towards breaking the chain of transmission and consequently controlling this endemic disease. Thus, the low effectiveness of treatment shown in flow chart 1 is a cause for concern and closely related to noncompliance and outbreaks of multiresistant tuberculosis [20] .
Poor compliance with the antimicrobial regimen has historically been cited as one of the most challenging problems for tuberculosis treatment [21] . It has become a focus of attention for national tuberculosis control programs in several countries, including Brazil, and has provoked the recent adoption of a strategy of establishing supervised treatment [22] .
In Brazil, the average rate of noncompliance with TB treatment in the early 1980s ranged from 10% to 16% [6] . By the 1990s, particularly in large urban centers, a cohort study carried out in 12 major cities by CNPS/ FNS/MS in 1992 reported 28% noncompliance among 2,054 patient records studied [9] . This was due to worsening socioeconomic conditions, the dismantling of the public health system, and an increase in HIV infection. These data are similar to those of an HDTAA study conducted in 1996 and 1997 [23] and the data in our study, carried out in 1998.
Countless factors have been associated with poor compliance with treatment, including its complexity and duration, adverse side effects, difficult access to health care services [15] [16] [17] , alcohol consumption [8] , lack of preventive treatment and unemployment [11] . Factors such as age, gender, color and educational level are usually not found to be predictors of poor compliance [11] . Studies that have evaluated factors associated with noncompliance with tuberculosis treatment using data gathered from patient records are usually limited. However, in this study, no significant difference was observed between data obtained at the hospital and those included from the analysis of the records of the state tuberculosis control program (unpublished data). Therefore, the data obtained from medical records probably provided good-quality information. Due to understaffing in the hospital's TB Program, there was no follow up for patients transferred to other health units.
We did not find some of the risk factors occasionally associated with increased noncompliance with TB treatment, such as being male, unemployed, and HIVpositive [11, 13, 16] . This may be due to the small sample size. However, other authors have also failed to confirm these associations [25, 26] . Alcohol consumption and living alone can predict noncompliance. This has also been found in other studies [17, 21] . Furthermore, an evaluation of supervised treatment found an 18% noncompliance rate, and alcohol consumption was one of the significant factors associated with noncompliance [26] . Most patients treated at HDTAA are residents of the city of Goiânia, however there was no significant variation regarding noncompliance when compared with patients from other cities in the State of Goiás. Preventive treatment has been cited as a factor associated with noncompliance [27] . However, we did not find such an association, probably because diagnosis had been confirmed before initiating treatment. Prior treatment and the need to use a form of drug therapy other than regimen I have also been reported as a predictive factor for noncompliance [8, 10, 16, 28] , which suggests that patients undergoing retreatment should be monitored more closely and, if possible, assigned to supervised treatment. The need for hospitalization was significantly greater for noncompliant patients, which demonstrates that hospitalization does not contribute to greater compliance and agrees with the analysis of Natal et al. [17] .
In the multivariate analysis the parameters, type of treatment regime used, need for hospitalization and lack of treatment by health care workers trained to treat TB patients continued to be associated with poor compliance. Oliveira and Moreira-Filho [8] reported that isolated cases of drug resistance are directly affect the success of treatment and irregularities in health care services are responsible for their lack of success. In a study of the results of tuberculosis treatment at 45 health care services in 14 Central American countries, Teixeira [29] reported that the main causes of noncompliance were a lack of sanitary education and a lack of organized health services. The First Brazilian Consensus on Tuberculosis (1977) concluded that the main factor responsible for noncompliance was problems in the structure and organization of health services, particularly poor or nonexistent tuberculosis control programs, which is the case with most general hospitals in the large urban centers of developing nations [6, 26] .
Conclusions
The degree of success of TB treatment in the city of Goiás observed in this study was not considered satisfactory. Factors associated with noncompliance with treatment, including the need for hospitalization for actual disease, specific treatment other than regimen I and treatment by unspecialized personel indicate a need to implement a tuberculosis control program in general hospitals and provide supervised treatment at least for patients with parameters considered predictive for noncompliance.
There should be more appropriate interaction with other primary and secondary health units and community programs established in the 1990s in Brazil, such as the Programa de Saúde da Família (Family Health Program).
If the results of this study are confirmed by other studies of patients treated by general hospitals, legislators responsible for public health policies should give priority to providing special treatment for tuberculosis patients at these units, particularly in large urban centers, establishing outpatient and hospitalbased tuberculosis control programs.
